This bill requires five major federal agencies (Social Security Administration, Medicare, IRS, VA, and HUD) to certify to Congress before implementing significant changes like staff cuts exceeding 5% in a year or closing over 5% of regional offices. Agencies must prove such changes won’t reduce benefits, delay payments, increase wait times, or weaken outreach for eligible individuals. An Inspector General must study the impact within one year and, if problems are found, require the agency to reverse the changes (e.g., reinstating staff or reopening offices). The law aims to safeguard access to retirement, health, tax, and housing benefits for millions of Americans.
Skinny Labels, Big Savings Act This bill provides a statutory safe harbor from patent infringement claims for generic or biosimilar manufacturers that seek or obtain approval for skinny labels of their drugs. Under current law, the Food and Drug Administration (FDA) may approve generic and biosimilar drugs through a process known as skinny labeling, which allows a generic manufacturer to seek approval only for approved uses of the drug that are no longer protected by patents. However, in GlaxoSmithKline LLC v. Teva Pharmaceuticals USA, Inc. , a court held that a generic manufacturer may sometimes be liable for patent infringement when it markets skinny label generics. The bill specifically lists the following as actions that are not considered infringement of a method of use claim in a patent under the Federal Food, Drug, and Cosmetic Act: submitting or seeking approval of a skinny label for a generic or biosimilar drug; promoting or commercially marketing a drug with skinny labeling approved by the FDA; or describing a drug product approved by the FDA as a generic of, or therapeutically equivalent to, the branded drug. The bill also applies the safe harbor to similar actions under the Public Health Service Act.
The Sarah Katz Caffeine Safety Act would require restaurants and retail food establishments with 20 or more locations to label menu items containing 150 milligrams or more of caffeine per serving with a "High caffeine" warning. It would mandate that packaged foods and dietary supplements with more than 10 milligrams of caffeine display the exact caffeine content, whether naturally occurring or added, along with a safety advisory about daily limits (400 milligrams for healthy adults). The bill directs the FDA to review caffeine safety in food and beverages, and the NIH to study caffeine's effects on vulnerable populations including children, pregnant women, and those with heart conditions or mental health conditions. It also requires a public education campaign about caffeine safety and a GAO study on the marketing of caffeinated beverages to children and teens, with reports due within 6 months and 180 days respectively.
HR 2372, the DEVICE Act of 2025, requires medical device manufacturers to notify the FDA before changing device designs or reprocessing instructions for devices sold across state lines. It also mandates that manufacturers report within 5 days any communications about device changes (like design, reprocessing, or safety concerns) sent to foreign healthcare providers. The bill defines "rapid assessment tests" for verifying proper reprocessing of reusable medical devices and requires manufacturers to provide validated instructions and data for these tests. This affects all manufacturers of reusable medical devices marketed in interstate commerce.
This bill would fund research into health impacts from chemicals in cosmetics used by communities of color and professional salon workers, with $7.5 million allocated for each research area. It requires cosmetic manufacturers to provide safety data sheets in multiple languages (English, Spanish, Vietnamese, Chinese, Korean) for salon products containing hazardous chemicals. The bill establishes two national resource centers to provide education, training, and culturally appropriate materials about safer cosmetic choices for underserved populations. It also regulates synthetic braids as cosmetics under FDA safety standards, requiring warning labels if safety standards aren't met.
HR 3432, the TDS Research Act of 2025, directs the National Institutes of Health (NIH) to study "Trump Derangement Syndrome" (TDS) through existing programs. The bill mandates NIH research on TDS's origins, long-term effects, contributing factors (like media coverage), and potential interventions, using current authorities without new funding. This research would be conducted by the National Institute of Mental Health and reported annually to Congress starting two years after enactment. The bill defines TDS as a phenomenon involving intense reactions to Donald J. Trump, but does not create new policy or directly affect individuals or communities. It is a procedural research directive, not a legislative change impacting public policy.
This bill creates a grant program to help family caregivers of older adults or individuals with disabilities. It provides funds to states, nonprofits, tribes, or senior centers to develop integrated services offering both respite care (temporary relief from caregiving) and additional support services in the same location. The program requires services to be accessible through translation, assistive technology, and multiple formats, including American Sign Language. It directly affects family caregivers, including older relatives (age 55+) caring for children or disabled individuals, who are not professional caregivers.
This bill changes TRICARE travel reimbursement rules by reducing the required distance for coverage from 100 miles to 50 miles for most beneficiaries seeking specialty care. It directly affects service members, veterans, and their families who travel for medical treatment outside their local area. The key provision lowers the threshold for reimbursement eligibility, making it easier to qualify for travel cost coverage. Military retirees and their dependents are also covered under the new 50-mile standard, previously subject to different rules.
HR 3183, the SAFE STEPS for Veterans Act of 2025, establishes a new Office of Falls Prevention within the Department of Veterans Affairs (VA) to coordinate and improve falls prevention efforts for veterans. The bill mandates that VA healthcare facilities conduct annual falls risk assessments and provide fall prevention services by licensed physical or occupational therapists for veterans at risk, and requires biennial staff training on safe patient handling techniques. It also creates a pilot program to test home modifications for fall prevention and directs the VA to report on current falls prevention practices, including screening methods, home modification grants, and medication management risks. This legislation directly affects veterans at risk of falls, VA healthcare facilities, and providers delivering care under VA programs.
HRES 1028 is a non-binding House resolution expressing the House's position that the U.S. must address billionaire economic and political influence. It calls for halting corporate tax breaks and subsidies, increasing taxes on the wealthy and corporations, and redirecting funds toward public services like healthcare, housing, and climate initiatives. As a resolution, it does not create new laws but states the House's view that concentrated wealth undermines democracy and requires policy changes to prioritize working people. It specifically references actions like breaking up corporate monopolies and expanding union support as part of this vision.
